Scott L Pomeroy
Overview
Explore the profile of Scott L Pomeroy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
41647
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Maynard R, Poore B, Hanaford A, Pham K, James M, Alt J, et al.
Cancer Lett
. 2021 Feb;
504:137-145.
PMID: 33571541
Medulloblastoma is the most common malignant pediatric brain tumor. Tumors having high levels of c-MYC have the worst clinical prognosis, with only a minority of patients surviving. To address this...
12.
Villafane J, Miller J, Glickstein J, Johnson J, Wagner J, Snyder C, et al.
Pediatr Cardiol
. 2021 Jan;
42(2):234-254.
PMID: 33388850
In the very young child (less than eight years of age), transient loss of consciousness represents a diagnostic and management dilemma for clinicians. While most commonly benign, syncope may be...
13.
Bhattacharya D, Pomeroy S, Pomeranz Krummel D, Sengupta S
J Neurooncol
. 2020 May;
150(1):77-83.
PMID: 32451770
Introduction: Brain tumors make up over a quarter of pediatric malignancies. Depending on the age of presentation and treatment, pediatric brain tumor survivors experience varying degrees of treatment induced morbidity...
14.
Grinspan Z, Mytinger J, Baumer F, Ciliberto M, Cohen B, Dlugos D, et al.
Ann Neurol
. 2020 May;
88(2):215-217.
PMID: 32445204
No abstract available.
15.
Li B, Vasiljevic A, Dufour C, Yao F, Ho B, Lu M, et al.
Acta Neuropathol
. 2019 Dec;
139(2):223-241.
PMID: 31820118
Pineoblastomas (PBs) are rare, aggressive pediatric brain tumors of the pineal gland with modest overall survival despite intensive therapy. We sought to define the clinical and molecular spectra of PB...
16.
Zhang L, He X, Liu X, Zhang F, Huang L, Potter A, et al.
Cancer Cell
. 2019 Sep;
36(3):302-318.e7.
PMID: 31474569
Progenitor heterogeneity and identities underlying tumor initiation and relapse in medulloblastomas remain elusive. Utilizing single-cell transcriptomic analysis, we demonstrated a developmental hierarchy of progenitor pools in Sonic Hedgehog (SHH) medulloblastomas,...
17.
Hovestadt V, Smith K, Bihannic L, Filbin M, Shaw M, Baumgartner A, et al.
Nature
. 2019 Jul;
572(7767):74-79.
PMID: 31341285
Medulloblastoma is a malignant childhood cerebellar tumour type that comprises distinct molecular subgroups. Whereas genomic characteristics of these subgroups are well defined, the extent to which cellular diversity underlies their...
18.
Walkley S, Abbeduto L, Batshaw M, Bhattacharyya A, Bookheimer S, Christian B, et al.
Ann Neurol
. 2019 Jun;
86(3):332-343.
PMID: 31206741
Progress in addressing the origins of intellectual and developmental disabilities accelerated with the establishment 50 years ago of the Eunice Kennedy Shriver National Institute of Child Health and Human Development...
19.
Northcott P, Robinson G, Kratz C, Mabbott D, Pomeroy S, Clifford S, et al.
Nat Rev Dis Primers
. 2019 Feb;
5(1):11.
PMID: 30765705
Medulloblastoma (MB) comprises a biologically heterogeneous group of embryonal tumours of the cerebellum. Four subgroups of MB have been described (WNT, sonic hedgehog (SHH), Group 3 and Group 4), each...
20.
Archer T, Ehrenberger T, Mundt F, Gold M, Krug K, Mah C, et al.
Cancer Cell
. 2018 Sep;
34(3):396-410.e8.
PMID: 30205044
There is a pressing need to identify therapeutic targets in tumors with low mutation rates such as the malignant pediatric brain tumor medulloblastoma. To address this challenge, we quantitatively profiled...